EUVIMEDEUVIMED entdecken
Leserbrief

In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus

Qian Wang, Ze Xiu Xiao, Xu Zheng, Guihong Wang, Linlin Yang, Lina Shi, Nan Xiang, Xingbing Wang, Gao-Feng Zha, Georg Schett, Zhu Chen iD

New England Journal of Medicine · 16.10.2025 · 393 (15) · 1542-1544

DOI: 10.1056/nejmc2509522 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, erschienen am 16.10.2025. Verfasst von Qian Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital of University of Science and Technology of China, Hefei. Die Arbeit wurde bisher 184-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Natural Science Foundation of Anhui Province, National Natural Science Foundation of China, Anhui University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • First Affiliated Hospital of University of Science and Technology of China, Hefei.
  • Shenzhen MagicRNA Biotechnology, Shenzhen, China.
  • Anqing Municipal Hospital, Anqing, China.
  • Anhui University of Science and Technology, Huainan, China.
  • Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.

ORCID-Profile: Zhu Chen

Förderung

  • Natural Science Foundation of Anhui Province
  • National Natural Science Foundation of China
  • Anhui University
  • Anhui Provincial Health Research Foundation
  • Anhui Provincial Natural Science Foundation
  • Shenzhen Science and Technology Program
  • Anhui Province University Scientific Research Program Project

Zitieren

APA

Wang, Q., Xiao, Z. X., Zheng, X., Wang, G., Yang, L., Shi, L., Xiang, N., Wang, X., Zha, G. F., Schett, G., & Chen, Z. (2025). In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus. New England Journal of Medicine, 393(15), 1542-1544. https://doi.org/10.1056/nejmc2509522

Vancouver

Wang Q, Xiao ZX, Zheng X, Wang G, Yang L, Shi L, et al. In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus. New England Journal of Medicine. 2025;393(15):1542-1544. doi:10.1056/nejmc2509522

BibTeX
@article{Wang2025,
  author = {Wang, Qian and Xiao, Ze Xiu and Zheng, Xu and Wang, Guihong and Yang, Linlin and Shi, Lina and Xiang, Nan and Wang, Xingbing and Zha, Gao-Feng and Schett, Georg and Chen, Zhu},
  title = {In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {15},
  pages = {1542--1544},
  doi = {10.1056/nejmc2509522}
}
Kostenlos starten →